Item 3.01- Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing
On April 20, 2023, AgeX received a letter (the "Deficiency Letter") from the
staff of the NYSE American (the "Exchange") indicating that AgeX does not meet
certain of the Exchange's continued listing standards as set forth in Sections
1003(a)(i), (ii), and (iii) of the Exchange Company Guide in that AgeX has
stockholders equity of less than (A) $2,000,000 and has incurred losses from
continuing operations and/or net losses during its two most recent fiscal years,
(B) $4,000,000 and has incurred losses from continuing operations and/or net
losses during three out of four of its most recent fiscal years, and (C) $6.0
million or more and has reported losses from continuing operations and/or net
losses in its five most recent fiscal years. The Deficiency Letter states that
as AgeX remains subject to the conditions set forth in prior letters from the
Exchange with respect to AgeX's deficiencies in stockholders equity, and if AgeX
is not in compliance with all of the Exchange's stockholders equity standards,
or does not make progress consistent with AgeX's Exchange approved plan to come
into compliance with the Exchange's continued listing standards, by May 17,
2023, the Exchange will initiate delisting proceedings as appropriate. AgeX may
appeal a staff delisting determination in accordance with Section 1010 and Part
12 of the Exchange Company Guide.
AgeX intends to make arrangements to have its common stock quoted on an
electronic interdealer quotation system if its common stock is delisted from the
Exchange.
Item 9.01 - Financial Statements and Exhibits.
Exhibit Number Description
99.1 Press release dated April 26, 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses